Biotinylated SARS-CoV-2 Nucleocapsid protein, His,Avitag (BA.2*&BA.3*/Omicron)
Specifications | |
---|---|
Category: | MABSol® Biotin Labeled Proteins |
Molecular Weight: | 48.8 kDa |
Tag: | C-6×His & C-Avi |
Label / Conjugate: | Biotin-labeled |
Source: | Biotinylated SARS-CoV-2 Nucleocapsid protein, His,Avitag (BA.2*&BA.3*/Omicron) (NUN-C82E9) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ala 419 (Accession # QHO62115.1 (P13L, ERS31-33del, R203K, G204R, S413R)). The nucleocapsid mutations are identified on the SARS-CoV-2 Omicron variant (Pango lineage: BA.2; GISAID clade: GRA; Nextstrain clade: 21L & Pango lineage: BA.3; GISAID clade: GRA; Nextstrain clade: 21M). |
Purity: | 90% |
Endotoxin Level: | 1.0 EU per μg |
Format: | Powder |
Additional Information | |
---|---|
Synonyms: | Nucleocapsid protein,NP,Protein N |
Organism: | SARS-CoV-2 |
Sequence Information
Met 1 - Ala 419
Background
Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool.
Price
533,00 €